The Use of Texting Messaging to Improve the Hospital-to-community Transition Period in Cardiovascular Disease Patients

• Register: ClinicalTrials.gov
• Last refreshed on: 16 December 2017
• Main ID: NCT02336919
• Date of registration: 08/01/2015
• Prospective Registration: Yes
• Primary sponsor: Simon Fraser University
• Public title: The Use of Texting Messaging to Improve the Hospital-to-community Transition Period in Cardiovascular Disease Patients Txt2Prevent
• Scientific title: The Use of Text Messaging to Improve the Hospital-community Transition and Prevent Readmission in Patients With Cardiovascular Disease (Txt2Prevent)
• Date of first enrolment: April 2015
• Target sample size: 76
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT02336919
• Study type: Interventional
• Study design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: Double (Investigator, Outcomes Assessor).
• Phase: N/A

Countries of recruitment

Canada

Contacts

• Name: Scott Lear, PhD
• Affiliation: Simon Fraser University

Key inclusion & exclusion criteria

Inclusion Criteria:

- are an acute coronary syndrome patient on the non-surgical ward who will be discharged
home

- own a phone with text-messaging capabilities and have the ability to access new text
messages

- have the ability to provide informed consent

- have the ability to read and understand English

Exclusion Criteria:

- have a pre-scheduled surgical procedure within the duration of the study

- if it is expected that they will not survive the duration of the study due to
non-cardiovascular reasons

- are currently enrolled in another research project regarding CVDs that would interfere
with the study outcomes.



Age minimum: 19 Years
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

Acute Coronary Syndrome

Cardiovascular Disease

Intervention(s)

Behavioral: Txt2Prevent

Primary Outcome(s)

Self-management as measured by the Health Education Impact Questionnaire by Osborne et al. [Time Frame: Pre- and post-study period (0 and 60 days)]

Secondary Outcome(s)

Hospital readmissions [Time Frame: Assessed at the end of the study (day 60)]

Medication Adherence as measured by the Morisky Medication Adherence Scale by Morisky et al. [Time Frame: Post-study period (60 days)]

Mortality [Time Frame: Assessed at the end of the study (day 60)]

Health-related quality of life as measured by the EuroQoL 5D-5L by the EuroQoL group [Time Frame: Pre- and post-study period (0 and 60 days)]

Secondary ID(s)

H14-02385

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

University of British Columbia

Canadian Institutes of Health Research (CIHR)

Providence Health & Services

McMaster University